Figure 1
Figure 1. Suppression of viral replication and CD8+ T-cell activation do not favor IL-15–induced CD4+ T-cell expansion. (A) Plasma SIV RNA copies at different days after introduction (gray box) or cessation of therapies. Each line represents a different animal. (B) Fold change in HLA-DR+CD8+ T cells after treatment initiation versus baseline (d−7) in TCM, TTM, and TEM cells. Bars show the interquartile range, and the wide bar shows the median, of the distribution. Each point represents an animal. (C) Fold change in CD4+ and CD8+ absolute T-cell counts in the peripheral blood in the different treatment groups. Data are expressed as in panel B. The horizontal gray line indicates no change versus baseline. #P < .05 vs ART; Wilcoxon rank-sum test.

Suppression of viral replication and CD8+ T-cell activation do not favor IL-15–induced CD4+ T-cell expansion. (A) Plasma SIV RNA copies at different days after introduction (gray box) or cessation of therapies. Each line represents a different animal. (B) Fold change in HLA-DR+CD8+ T cells after treatment initiation versus baseline (d−7) in TCM, TTM, and TEM cells. Bars show the interquartile range, and the wide bar shows the median, of the distribution. Each point represents an animal. (C) Fold change in CD4+ and CD8+ absolute T-cell counts in the peripheral blood in the different treatment groups. Data are expressed as in panel B. The horizontal gray line indicates no change versus baseline. #P < .05 vs ART; Wilcoxon rank-sum test.

Close Modal

or Create an Account

Close Modal
Close Modal